Study reveals women face 74% higher risk of psychosomatic misdiagnosis for autoimmune diseases

Key points

• Women are 74% more likely than men to have autoimmune symptoms misdiagnosed as psychosomatic, and 46% more likely to receive psychiatric misdiagnoses.
• Women face much longer diagnostic delays, with most waiting one to two years, compared to men who are often diagnosed within three months.
• The study, involving over 6,600 patients, found that 43% of women and 33% of men reported previous psychiatric misdiagnoses.
• Researchers emphasize that while psychiatric and autoimmune conditions can coexist, clinicians should not prematurely attribute symptoms to psychological causes without ruling out autoimmune diseases.
• Historical gender biases, including the perception of women as less credible reporters of symptoms, continue to impact diagnostic accuracy and treatment timelines.

Background

This finding aligns with broader patterns of gender-based disparities in healthcare. A recent study highlighted that women are less likely than men to receive active medical treatments for identical conditions, including heart disease and kidney failure. Additionally, earlier coverage noted that women often face underdiagnosis of conditions like peripheral artery disease due to atypical symptoms, further illustrating systemic challenges in recognizing and addressing women's health issues accurately.

How outlets are covering it

The Guardian and Euronews both emphasize the stark gender divide in diagnostic delays and misdiagnosis, citing the same study data. The Guardian focuses on the long-term impact of misdiagnosis on women's trust in doctors and self-esteem, while Euronews highlights the broader implications for healthcare systems and the need for clinicians to be open-minded. UA.NEWS provides a more detailed breakdown of the statistical differences, noting that men were slightly more likely to receive incorrect diagnoses of other physical diseases. All sources agree on the need for improved diagnostic practices, but the Guardian and Euronews place greater emphasis on the historical biases and gender-specific challenges, while UA.NEWS focuses more on the statistical and methodological aspects of the study.

Why it matters

The findings underscore the critical need for addressing gender-based disparities in healthcare, particularly in the diagnosis and treatment of autoimmune diseases. Misdiagnosis and delayed treatment can lead to prolonged suffering, untreated conditions, and a loss of trust in the healthcare system. By highlighting these disparities, the study calls for a shift in clinical practices to ensure that women's symptoms are taken seriously and accurately diagnosed, ultimately improving health outcomes and equity in healthcare.

What to watch

The study's findings are likely to prompt further discussions and research into gender-based disparities in healthcare. Clinicians may be encouraged to adopt more thorough diagnostic practices, considering autoimmune diseases before attributing symptoms to psychological causes. Additionally, the findings may lead to increased awareness and advocacy for women's health issues, pushing for more inclusive and equitable healthcare policies and practices.